Michael R. Ujhelyi, Pharm.D., FCCP is medical director at Delcath Systems and holds the adjunct professor of pharmacy appointment at University of Florida. He is responsible for the overall medical and clinical affairs strategies for Delcath’s North American business. Prior to joining Delcath, Michael was a professor of pharmacy at the University of Florida and associate dean responsible for the overall operations for the academic and research enterprises. Previously, Michael was senior regional medical director for BTG, leading the interventional oncology field medical team, therapy training and education, clinical trial liaison/investigator initiated research, executing medical plans and supporting internal stakeholders. From 2016 to 2017, he was the vice president of research and scientific affairs at the Minneapolis Heart Institute Foundation, where he led an $8M research enterprise. Michael was the medical affairs and clinical research director of Medtronic Neuromodulation and Cardiac Rhythm business units, respectively, at Medtronic between 1998 and 2016. From 1993 until 1998, he worked as an associate professor of pharmacy and medicine at the University of Georgia College of Pharmacy and Medicine.
Michael has been instrumental in the development and commercialization of numerous medical devices and drug/device combination products, He has designed and developed many programs including an investigator initiated research program, field based medical scientist program, oncology medical science liaison organization, medical evidence centers and medical information program. He is an internationally recognized scientist and industry leader for Clinical and Medical Affairs. He has led large clinical research initiatives, developed cardiovascular, neuromodulation and oncology device based therapies and has published over 70 research papers, presented more than 100 research papers at scientific meetings and has 26 issued patents.
Michael has mentored many start up companies typically in the area of clinical research and medical affairs. He also serves as a senior consultant to developing companies. He received his bachelor’s in pharmacy from the University of Florida (1987), Doctor of Pharmacy from the University of North Carolina at Chapel Hill (1989) and completed a cardiovascular therapeutics fellowship at Hartford Hospital and University of Connecticut (1991). Outside of the office, Michael enjoys various outdoor activities, reading, traveling, and walking his dog.